Education
About Us
Working with TipRanks
Follow Us
Genprex (GB:0A8I)
:0A8I
0A8I Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.22 - $3.94
Previous CloseN/A
Volume36.71K
Average Volume (3M)41.51K
Market Cap
$6.44M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.60M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-2.33
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding24,152,847
10 Day Avg. Volume8,182
30 Day Avg. Volume41,507
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Genprex News
PremiumCompany Announcements
Genprex Delays Yearly Report Filing
PremiumCompany Announcements
Genprex Strengthens Diabetes Focus with New License
---
Options Prices
Currently, No data available
---
Ownership Overview
0.35% Insiders
0.14%
Mutual Funds
0.34% Other Institutional Investors
99.10% Public Companies and
Individual Investors
0A8I FAQ
What was Genprex’s price range in the past 12 months?
Genprex lowest share price was $0.22 and its highest was $3.94 in the past 12 months.
What is Genprex’s market cap?
Genprex’s market cap is $6.44M.
When is Genprex’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genprex’s earnings last quarter?
Genprex released its earnings results on May 15, 2019. The company reported -$0.141 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.141.
Is Genprex overvalued?
According to Wall Street analysts Genprex’s price is currently Overvalued.
Does Genprex pay dividends?
Genprex does not currently pay dividends.
What is Genprex’s EPS estimate?
Genprex’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genprex have?
Genprex has 24,152,847 shares outstanding.
What happened to Genprex’s price movement after its last earnings report?
Genprex reported an EPS of -$0.141 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Genprex?
Currently, no hedge funds are holding shares in GB:0A8I
---
Company Description
Genprex
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
---
0A8I Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Brainstorm Cell Therapeutics
―
GT Biopharma
―
Aptorum Group
―
Lyra Therapeutics
―
Conduit Pharmaceuticals
―
Best Analysts Covering 0A8I
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-88.77%
reiterated a buy rating 11 months ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -88.77% per trade.
---